Claudin-2 extracellular loop 1-mimetic peptides functionally inhibit combined hepatocellular-cholangiocarcinoma cells
Open Access
- 1 July 2026
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare and aggressive liver cancer for which effective targeted therapies have not been established. We analyzed claudin expression in cHCC-CCA cell lines (KMCH-1 and KMCH-2) and found that claudin-2 was markedly overexpressed relative to hepatocellular carcinoma and cholangiocarcinoma cell lines, as well as primary hepatocytes. This upregulation was associated with the Wnt/β-catenin signaling pathway, a major regulator of cell proliferation. Claudin-2 knockdown reduced cell viability in both cHCC-CCA cell lines examined, suggesting that claudin-2 supports viability in these cell line models. To test whether claudin-2 function can be modulated extracellularly, we synthesized peptides mimicking the first extracellular loop (ECL1) of claudin-2. Among them, the C-terminal peptide Ex1C selectively reduced the viability of cHCC-CCA cell lines examined, but not that of other cells lacking claudin-2 overexpression. Ex1C suppressed proliferation without inducing cell death and significantly inhibited adhesion of KMCH-2 and KMCH-1 cells to primary hepatocytes. As Ex1C exhibited homotypic self-association, these effects are consistent with interference with ECL1-dependent claudin-2 interactions. Collectively, our findings identify claudin-2 as a characteristic molecular feature of the examined cHCC-CCA cell lines and support the utility of extracellular loop-mimetic peptides as probes to dissect claudin-dependent regulation of proliferation and cell adhesion.Keywords
Funding Information
- Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (24K10046)
This publication has 57 references indexed in Scilit:
- Establishment of two novel organoid lines from patients with combined hepatocellular cholangiocarcinomaHuman Cell, 2024
- PPM1G Inhibits Epithelial–Mesenchymal Transition in Cholangiocarcinoma by Catalyzing TET1 Dephosphorylation for Destabilization to Impair Its Targeted Demethylation of the CLDN3 PromoterAdvanced Science, 2024
- Possibility of Targeting Claudin-2 in Therapy for Human Endometrioid Endometrial CarcinomaReproductive Sciences, 2020
- Management and outcomes among patients with mixed hepatocholangiocellular carcinoma: A population‐based analysisJournal of Surgical Oncology, 2018
- PDZRN3 regulates differentiation of myoblasts into myotubes through transcriptional and posttranslational control of Id2Journal of Cellular Physiology, 2018
- Claudins-4 and -7 might be valuable markers to distinguish hepatocellular carcinoma from cholangiocarcinomaVirchows Archiv, 2016
- Increase in claudin-2 expression by an EGFR/MEK/ERK/c-Fos pathway in lung adenocarcinoma A549 cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- Claudin-18 in biliary neoplasms. Its significance in the classification of intrahepatic cholangiocarcinomaVirchows Archiv, 2011
- Claudins and tricellulin in fibrolamellar hepatocellular carcinomaVirchows Archiv, 2011
- Establishment and characterization of a human combined hepatocholangiocarcinoma cell line and its heterologous transplantation in nude miceHepatology, 1987